ConductScience.org, home

Paper39698264

Advances in Development of Drug Treatment for Hemophilia with Inhibitors.

Wichaiyo S. ACS Pharmacol Transl Sci, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Advances in Development of Drug Treatment for Hemophilia with Inhibitors. Papers, record 39698264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39698264

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances in Development of Drug Treatment for Hemophilia with Inhibitors.
PubMed
Journal
ACS Pharmacol Transl Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.07, provisional
iCite
Revised in PubMed
2025-11-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wichaiyo SSurasakhttps://orcid.org/0000-0002-1343-7055

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134077951A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice.Blood2021https://conductscience.org/library/papers/34077951PubMed
230151972Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia.J Thromb Haemost2018https://conductscience.org/library/papers/30151972PubMed
338142846FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic.J Thromb Haemost2024https://conductscience.org/library/papers/38142846PubMed
412781551Haemophilias A and B.Lancet2003https://conductscience.org/library/papers/12781551PubMed
530174468An investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia A and B.J Blood Med2018https://conductscience.org/library/papers/30174468PubMed
627913543Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches.Hematology Am Soc Hematol Educ Program2016https://conductscience.org/library/papers/27913543PubMed
725428222Toward optimal therapy for inhibitors in hemophilia.Blood2014https://conductscience.org/library/papers/25428222PubMed
828691557Emicizumab Prophylaxis in Hemophilia A with Inhibitors.N Engl J Med2017https://conductscience.org/library/papers/28691557PubMed
935999026A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia.Br J Haematol2023https://conductscience.org/library/papers/35999026PubMed
1030264916The future of bypassing agents for hemophilia with inhibitors in the era of novel agents.J Thromb Haemost2018https://conductscience.org/library/papers/30264916PubMed
1115328151The use of recombinant factor VIIa in the treatment of bleeding disorders.Blood2004https://conductscience.org/library/papers/15328151PubMed
1226897598The past and future of haemophilia: diagnosis, treatments, and its complications.Lancet2016https://conductscience.org/library/papers/26897598PubMed
1337646676Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.N Engl J Med2023https://conductscience.org/library/papers/37646676PubMed
1417951326The haemostatic role of tissue factor pathway inhibitor.Arterioscler Thromb Vasc Biol2008https://conductscience.org/library/papers/17951326PubMed
1531859415Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline.Haemophilia2020https://conductscience.org/library/papers/31859415PubMed
1638523289Haemophilia care in Asia: Learning from clinical practice in some Asian countries.Haemophilia2024https://conductscience.org/library/papers/38523289PubMed
1732744769WFH Guidelines for the Management of Hemophilia, 3rd edition.Haemophilia2020https://conductscience.org/library/papers/32744769PubMed
1837916312Emicizumab: the hemophilia A game-changer.Haematologica2024https://conductscience.org/library/papers/37916312PubMed
1937341887Concizumab: First Approval.Drugs2023https://conductscience.org/library/papers/37341887PubMed
2028670147Many factor VIII products available in the treatment of hemophilia A: an embarrassment of riches?J Blood Med2017https://conductscience.org/library/papers/28670147PubMed

See all 65 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42078236Clinical Scenarios in Hospitalized Patients With Hemophilia.Cureus2026https://conductscience.org/library/papers/42078236PubMed
41892982Structural Enablers of Rare Disease Treatment Coverage in Latin America and the Caribbean: Lessons from Emicizumab.J Mark Access Health Policy2026https://conductscience.org/library/papers/41892982PubMed
41473775Rebalancing Hemostasis: Fitusiran as a First-in-Class RNAi Therapy in Hemophilia A and B.Health Sci Rep2026https://conductscience.org/library/papers/41473775PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SERPINC1462PubTator's text mininghttps://conductscience.org/library/genes/462

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39698264

GET https://conductscience.org/api/papers/v1/39698264/references?page=2